# Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

> **NCT02962310** · PHASE1 · COMPLETED · sponsor: **Torrent Pharmaceuticals Limited** · enrollment: 48 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Torrent's Rosuvastatin Calcium Tablets 40 mg
- **DRUG:** Crestor 40 mg Tablets of AstraZeneca LP, USA

## Key facts

- **NCT ID:** NCT02962310
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02962310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02962310, "Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02962310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*